查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1499985

全球数位治疗市场评估：依产品、应用、收入模式、销售管道、地区、机会、预测（2017-2031）

Digital Therapeutics Market Assessment, By Product, By Application, By Revenue Model, By Sales Channel, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

全球数位治疗市场规模预计将从 2023 年的 63.9 亿美元增至 2031 年的 278.4 亿美元，预计 2024-2031 年复合年增长率为 20.20%。该市场近年来呈现显着成长，预计未来将保持强劲的扩张速度。

用于预防、管理和治疗疾病和医学病症的基于证据、软体驱动的疗法被称为 "数位疗法" 或 "DTx" 。这些尖端治疗方法旨在成为有效的治疗计划。 DTx 通常与药物、设备和其他治疗结合使用。 DTX 解决方案利用尖端技术，使患者能够采取治疗行动，并在改善健康方面发挥积极作用。不断发展的数位治疗领域可以扩大治疗选择，帮助医生促进客製化治疗并解决各种疾病。数位疗法有可能彻底改变疾病的治疗和预防方式，从而改善患者的治疗结果和整个过程中的整体医疗服务。数位治疗市场受到多种因素的推动，包括糖尿病和癌症等可预防慢性疾病的流行、降低医疗成本的愿望、对数位治疗的投资增加以及对预防性医疗保健的日益关注。

世界各国政府对预防性医疗保健的日益重视是数位治疗产业的主要成长动力之一。各国政府正在放弃传统医疗技术，并透过实施计划和程序来增加这些设备的使用。智慧型手机和平板电脑设备使用量的增加预计将推动数位医疗保健应用程式和平台的扩展，并在未来几年扩大市场。由于慢性病盛行率不断上升以及控制医疗设施成本不断上升的需求日益增长，预计该市场将会发展。此外，消费者越来越习惯在各个行业使用数位平台，健康意识的提高是市场成长的关键驱动力之一。

例如，2024 年4 月，医护人员和行业专家称讚中央政府医疗保健计划(CGHS) 受益人ID 与Ayushman Bharat 健康帐户(ABHA) 号码的强制关联，证明了其在彻底改变医疗可及性和数位健康方面的重要性。该举措可以透过提供医疗服务的无缝整合和加强以患者为中心的护理来重塑医疗保健格局。

网路普及促进市场成长

随着智慧型手机和网路的普及，数位治疗市场预计将大幅成长。数位治疗是一个新兴的医学领域，利用数位技术来治疗各种医疗/心理问题。由于其广泛采用，智慧型手机透过为这些治疗提供平台，在这一增长中发挥有用且重要的作用。透过避免旅行接受治疗和咨询，患者可以在需要时轻鬆获得治疗干预措施。此外，互联网使用的快速增长将促进数位疗法的开发和易用性。高速网路存取使得复杂的应用程式和演算法的实施成为可能，这些应用程式和演算法可以立即将患者与专家联繫起来，提供量身定制的治疗，并即时追踪患者的健康状况。因此，随着智慧型手机和网路连线的日益普及，数位疗法的采用和需求预计将会增加。

本报告研究和分析了全球数位治疗市场，提供市场规模和预测、市场动态以及主要参与者的现状和前景。

目录

第一章研究方法

第 2 章专案范围与定义

第 3 章执行摘要

第四章全球数位治疗市场展望（2017-2031）

  • 市场规模与预测
    • 金额
    • 数量
  • 依产品
    • 设备
    • 软体、服务
  • 依用途
    • 预防
    • 治疗
  • 依获利模式
    • 基于订阅的模式
    • 一次性购买/每年许可模式
    • 基于结果/价值的模型
  • 依销售管道
    • B2B 销售通路
    • B2C 销售管道
  • 依地区
    • 北美
    • 欧洲
    • 亚太地区
    • 南美洲
    • 中东/非洲
  • 市占率：依公司划分（2023 年）

第 5 章全球数位治疗市场展望：依地区划分（2017-2031 年）

  • 北美
    • 市场规模与预测
    • 依产品
    • 依用途
    • 依获利模式
    • 依销售管道
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 英国
    • 俄罗斯
    • 荷兰
    • 西班牙
    • 土耳其
    • 波兰
  • 亚太地区
    • 印度
    • 中国
    • 日本
    • 澳大利亚
    • 越南
    • 韩国
    • 印尼
    • 菲律宾
  • 南美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 南非

第 6 章市场地图（2023 年）

  • 依产品
  • 依用途
  • 依获利模式
  • 依销售管道
  • 依地区

第七章宏观环境与产业结构

  • 需求与供给分析
  • 进出口分析
  • 价值链分析
  • PESTEL 分析
  • 波特五力分析

第 8 章市场动态

  • 生长促进因素
  • 抑製成长的因素（问题、限制因素）

第 9 章监理架构与创新

  • 临床试验
  • 监理机关的核准
  • 创新/新技术

第十章主要公司状况

  • 前 5 名市场领导者的竞争矩阵
  • 前 5 位市场领导者的市场收入分析（2023 年）
  • 併购/合资企业（如果适用）
  • SWOT 分析（5 家市场公司）
  • 专利分析（如果适用）

第11章价格分析

第 12 章案例研究

第十三章主要公司展望

  • Noom, Inc.
  • Kaia Health Software, Inc.
  • Welldoc, Inc.
  • Better Therapeutics, Inc.
  • Vida Health, Inc.
  • 2Morrow Health, Inc.
  • Omada Health, Inc.
  • Akili Interactive Labs, Inc.
  • Teladoc Health, Inc.
  • ConigFit Inc.

第 14 章策略建议

第十五章关于我们公司，免责声明

Product Code: MX11523

Global digital therapeutics market is projected to witness a CAGR of 20.20% during the forecast period 2024-2031F, growing from USD 6.39 billion in 2023 to USD 27.84 billion in 2031F. The market has experienced significant growth in recent years and is expected to maintain a strong pace of expansion in the coming years.

Software-driven, evidence-based therapeutic treatments for the prevention, management, or treatment of diseases or medical disorders are referred to as "digital therapeutics" or "DTx." These cutting-edge interventions are made to resemble efficient treatment plans. They frequently work in conjunction with drugs, equipment, or other types of therapies. Using state-of-the-art technology, DTX solutions enable patients to adopt therapeutic behaviors that take an active role in their health outcomes. The expanding field of digital therapeutics offers a wide array of enhanced treatment alternatives to physicians, facilitating customized care and tackling a wide range of ailments. Digital medicines have the potential to completely change the way we treat and prevent illnesses, improving patient outcomes and overall healthcare delivery in the process. The market for digital therapeutics is expanding due to several factors, including the growing prevalence of chronic diseases like diabetes and cancer that can be prevented, the desire to reduce healthcare costs, higher investments in digital medications, and an increasing emphasis on preventive healthcare.

The growing emphasis that governments worldwide place on preventative healthcare is one of the main factors propelling the growth of the digital therapeutics industry. Governments are moving away from traditional healthcare techniques and increasing the use rate of these gadgets through the implementation of programmes and procedures. The rising usage of smartphones and tablets is projected to drive the expansion of digital healthcare applications and platforms, which is expected to propel the market over the coming years. The market is projected to develop due to the increased prevalence of chronic diseases and the growing need to control the rising cost of healthcare facilities. In addition, consumers are becoming more accustomed to using digital platforms across various industries, and rising health and fitness consciousness is one of the main drivers of the market's growth.

For instance, in April 2024, medical professionals along with industry experts have extoled the mandatory linking of Central Government Healthcare Scheme (CGHS) beneficiary's IDs with Ayushman Bharat Health Account (ABHA) numbers and have suggested the significance of revolutionizing healthcare accessibility and digital health management. This initiative can reshape the healthcare landscape by offering a seamless integration of healthcare services and enhancing patient-focused care.

Increasing Internet Penetration Leads to Market Growth

The market for digital therapies is predicted to grow dramatically as smartphone and internet adoption increases. Due to its accessibility and convenience, digital and online health technologies are being adopted more and more in digital therapeutics, a newer healthcare discipline that uses them to treat a range of medical and psychological issues. Due to their widespread use, smartphones have been useful and important in this rise by giving these therapies a platform. Avoiding travel for treatments or in-person medical consultations allows patients to obtain therapeutic interventions effortlessly and whenever needed. Moreover, the quick rise in internet usage promotes digital medicines' development and usability. High-speed internet access has made it feasible to implement complex apps and algorithms that can instantaneously link patients with medical specialists, offer tailored treatments, and track patients' health in real-time. Therefore, it is anticipated that the market will see a rise in the adoption and demand for digital treatments in line with the increasing prevalence of smartphones and internet connectivity.

The digital therapeutics industry is expected to experience significant expansion, primarily because telehealth and remote patient monitoring (RPM) systems are becoming more widely used. The demand for digital therapies is anticipated to increase as patients and healthcare professionals become more accustomed to using these technologies. Personalized treatment plans, ongoing patient monitoring, and distant consultations are made possible via telehealth and RPM systems. In addition to being convenient, this allows patients to participate actively in their treatment process. Furthermore, in areas where traditional care delivery models frequently falter, such as the management of general well-being, mental health concerns, and chronic illnesses, new technologies hold promise. Consequently, demand for digital therapies is expected to soar as healthcare continues to digitize due to its potential to revolutionize patient experience and care delivery.

For instance, conducting a ground-breaking project in April 2024 to transform healthcare via a digital platform that will allow easy access to medical services throughout the state is the Department of Health and Family Welfare. With the introduction of a digital health service similar to an Aadhaar card, individuals can avail the treatment at any healthcare facility across any state, avoiding any geographical barriers.

Expansion of Market Due to Growing Need for Cost-Effective Healthcare

One problem that most of the population faces is the rising cost of healthcare. The need for more affordable healthcare is increasing as costs keep rising, which is expected to drive the demand for digital therapies. Digital therapies are a new healthcare service that is becoming increasingly popular. They are used to treat medical diseases economically. By utilizing digital tools and technologies, these health solutions aim to prevent, manage, or treat various behavioral, mental, and physical health issues. These solutions are especially attractive since they can improve access to care while remaining cost-effective. Digital therapies have a remarkable potential to lower healthcare delivery costs. They may lessen the need for in-person consultations by substituting them with digital consultations, which are more economical and require less time. Digital medicines can also offer real-time feedback and monitoring, facilitating early intervention and minimizing the need for expensive hospital stays or treatments. The need for these creative, economical solutions is predicted to soar worldwide as healthcare expenses keep rising.

For instance, in July 2022, Cencora, Inc. announced the launch of DTx Connect, a platform that combines ordering, dispensing, and fulfillment seamlessly to facilitate patient access to digital therapies and diagnostics from the comfort of their homes requested by physicians. Doctors can easily access prescription and non-prescription software through the platform's integration with electronic medical records (EMR).

Increasing Dominance of Treatment/Care Application Segment to Fuel Market Growth

As per the most recent trends in the digital therapeutics market, the treatment/care application segment is expected to hold a substantial proportion. A wide range of medical illnesses, such as substance misuse, mental health disorders, diabetes, respiratory disorders, and cardiovascular diseases, can be treated and cared for with software-based interventions. The market is being driven by an increase in the need for effective and convenient treatment alternatives due to a global rise in the prevalence of chronic illnesses. Digital therapeutics' personalized interventions can support patients in managing their diseases, keeping an eye on their health, and adhering to their treatment plans. These tactics can range from medication reminders and symptom monitoring to online coaching and cognitive behavioral therapy. Patients can now receive care and treatment at their fingertips because of technological advancements like wearables and smartphone applications. By offering personalized suggestions, educational resources, and instantaneous feedback, these digital solutions empower individuals to participate actively in their healthcare.

For instance, in June 2023, Spokane Regional Health District (SRHD) released a new app called 2Morrow Health Inc., a product of the Washington State Department. The app assists users in making a strategy to help them manage smoking or vaping by providing tools that can control cravings and monitor their progress toward quitting.

Similarly, in March 2022, Curebase, Inc. and Blue Note Therapeutics, Inc. partnered to conduct a home-based clinical trial of prescription digital therapeutics to help people with cancer enhance their results and improve their mental health.

North America to Dominate the Digital Therapeutics Market

North America is anticipated to hold the greatest proportion of the digital therapeutics market. The region's market dynamics are being fueled by increased R&D spending. North America, especially the United States, is renowned for its technological and digital innovation breakthroughs. The area is well-suited for creating and using digital medicine solutions due to its strong infrastructure, high degree of digital literacy, and supportive environment. Increased financing for digital pharmaceuticals is driving North American market numbers. Government initiatives, venture capital firms, and private equity funds are assisting in developing and localizing digital therapies. The United States is promoting partnerships among academic institutions, healthcare providers, and firms that develop digital therapies. Consequently, the growth in partnerships between digital therapeutics startups, major pharmaceutical corporations, and technology firms is what is propelling the digital therapeutics market in North America. Digital treatments are being used by patients, payers, and healthcare professionals at a growing rate in North America. The area boasts a culture that embraces technology to improve healthcare and a high level of digital literacy. In the United States, a clear regulatory framework for digital therapies has been established. Digital therapy evaluation and approval follow protocols and rules set by the Food and Drug Administration (FDA). This regulatory clarity makes it easier and more confident for digital therapeutics businesses to enter the market. For instance, Vida Health, Inc. and Capital Rx, LLC collaborated to launch Rx Activate, a high-touch chronic illness treatment program, in November 2023 in New York.

Similarly, Vida Health, Inc. and Withings Health Solutions partnered in November 2023 to improve virtual cardiometabolic care with the integration of potent health monitors in Boston.

Future Market Scenario (2024-2031F)

One of the main factors contributing to the anticipated growth of the global digital therapeutics market is the increasing prevalence of chronic disorders, increasing geriatric population and increasing demand for affordable healthcare services. Rising internet penetration and involvement of people with technology are also factors that will always propel the market growth in the future. Given that technology is advancing, cutting-edge technology in the area can also be expected. Players in this market are expanding at an unparalleled rate, introducing cost-effective and efficient technologies. For instance, Better Therapeutics, Inc. announced in October 2023 that AspyreRx, the first cognitive behavioral therapy (CBT) app, would go on sale for the treatment of adult patients with type 2 diabetes (T2D).

Key Players Landscape and Outlook

Several companies such as Noom, Inc., Kaia Health Software, Inc., Welldoc, Inc., Better Therapeutics, Inc., Vida Health, Inc., 2Morrow Health Inc., Omada Health, Inc., Akili Interactive Labs, Inc., Teladoc Health, Inc., ConigFit Inc., etc., are expanding business by planning and adopting new strategies. They are complying with new strategic initiatives regarding the launches of newly developed digital platforms to help researchers and to bring up their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments and partnerships are a few ways through which they are trying to achieve the same.

To commercialize digital therapies and enable patients to have more control over their own health through digital solutions, Mahana Therapeutics, Inc. and the Consumer Health division of Bayer AG came together into a distribution and marketing partnership in August 2023.

To improve patients' experiences with physical therapy, Kaia Health Software, Inc. introduced Angela in June 2023. Angela is a voice-activated, AI-powered digital care assistant, companion, and guide that complies with Health Insurance Portability and Accountability Act regulations.

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Digital Therapeutics Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Product
    • 4.2.1. Devices
    • 4.2.2. Software and Services
  • 4.3. By Application
    • 4.3.1. Prevention
      • 4.3.1.1. Prediabetes
      • 4.3.1.2. Obesity
      • 4.3.1.3. Nutrition
      • 4.3.1.4. Lifestyle Management
      • 4.3.1.5. Others
    • 4.3.2. Treatment
      • 4.3.2.1. Diabetes
      • 4.3.2.2. Mental Health Related Disorders
      • 4.3.2.3. Smoking Cessation
      • 4.3.2.4. Chronic Respiratory Diseases
      • 4.3.2.5. Musculoskeletal Disorders
      • 4.3.2.6. Cardiovascular Disorders
      • 4.3.2.7. Gastrointestinal Disorders
      • 4.3.2.8. Rehabilitation and Patient Care
      • 4.3.2.9. Others
  • 4.4. By Revenue Model
    • 4.4.1. Subscription-Based Model
    • 4.4.2. One-Time Purchase/Annual Licensing Model
    • 4.4.3. Outcome/Value-Based Model
  • 4.5. By Sales Channel
    • 4.5.1. B2B Sales Channel
      • 4.5.1.1. Payers
      • 4.5.1.2. Employers
      • 4.5.1.3. Pharmaceutical Companies
      • 4.5.1.4. Providers
    • 4.5.2. B2C Sales Channel
      • 4.5.2.1. Caregivers
      • 4.5.2.2. Patients
  • 4.6. By Region
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia-Pacific
    • 4.6.4. South America
    • 4.6.5. Middle East and Africa
  • 4.7. By Company Market Share (%), 2023

5. Global Digital Therapeutics Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Product
      • 5.1.2.1. Devices
      • 5.1.2.2. Software and Services
    • 5.1.3. By Application
      • 5.1.3.1. Prevention
        • 5.1.3.1.1. Prediabetes
        • 5.1.3.1.2. Obesity
        • 5.1.3.1.3. Nutrition
        • 5.1.3.1.4. Lifestyle Management
        • 5.1.3.1.5. Others
      • 5.1.3.2. Treatment
        • 5.1.3.2.1. Diabetes
        • 5.1.3.2.2. Mental Health Related Disorders
        • 5.1.3.2.3. Smoking Cessation
        • 5.1.3.2.4. Chronic Respiratory Diseases
        • 5.1.3.2.5. Musculoskeletal Disorders
        • 5.1.3.2.6. Cardiovascular Disorders
        • 5.1.3.2.7. Gastrointestinal Disorders
        • 5.1.3.2.8. Rehabilitation and Patient Care
        • 5.1.3.2.9. Others
    • 5.1.4. By Revenue Model
      • 5.1.4.1. Subscription-Based Model
      • 5.1.4.2. One-Time Purchase/Annual Licensing Model
      • 5.1.4.3. Outcome/Value-Based Model
    • 5.1.5. By Sales Channel
      • 5.1.5.1. B2B Sales Channel
        • 5.1.5.1.1. Payers
        • 5.1.5.1.2. Employers
        • 5.1.5.1.3. Pharmaceutical Companies
        • 5.1.5.1.4. Providers
      • 5.1.5.2. B2C Sales Channel
        • 5.1.5.2.1. Caregivers
        • 5.1.5.2.2. Patients
    • 5.1.6. United States*
      • 5.1.6.1. Market Size & Forecast
        • 5.1.6.1.1. By Value
        • 5.1.6.1.2. By Volume
      • 5.1.6.2. By Product
        • 5.1.6.2.1. Devices
        • 5.1.6.2.2. Software and Services
      • 5.1.6.3. By Application
        • 5.1.6.3.1. Prevention
          • 5.1.6.3.1.1. Prediabetes
          • 5.1.6.3.1.2. Obesity
          • 5.1.6.3.1.3. Nutrition
          • 5.1.6.3.1.4. Lifestyle Management
          • 5.1.6.3.1.5. Others
        • 5.1.6.3.2. Treatment
          • 5.1.6.3.2.1. Diabetes
          • 5.1.6.3.2.2. Mental Health Related Disorders
          • 5.1.6.3.2.3. Smoking Cessation
          • 5.1.6.3.2.4. Chronic Respiratory Diseases
          • 5.1.6.3.2.5. Musculoskeletal Disorders
          • 5.1.6.3.2.6. Cardiovascular Disorders
          • 5.1.6.3.2.7. Gastrointestinal Disorders
          • 5.1.6.3.2.8. Rehabilitation and Patient Care
          • 5.1.6.3.2.9. Others
      • 5.1.6.4. By Revenue Model
        • 5.1.6.4.1. Subscription-Based Model
        • 5.1.6.4.2. One-Time Purchase/Annual Licensing Model
        • 5.1.6.4.3. Outcome/Value-Based Model
      • 5.1.6.5. By Sales Channel
        • 5.1.6.5.1. B2B Sales Channel
          • 5.1.6.5.1.1. Payers
          • 5.1.6.5.1.2. Employers
          • 5.1.6.5.1.3. Pharmaceutical Companies
          • 5.1.6.5.1.4. Providers
        • 5.1.6.5.2. B2C Sales Channel
          • 5.1.6.5.2.1. Caregivers
          • 5.1.6.5.2.2. Patients
    • 5.1.7. Canada
    • 5.1.8. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East and Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Product
  • 6.2. By Application
  • 6.3. By Revenue Model
  • 6.4. By Sales Channel
  • 6.5. By Region

7. Macro Environment and Industry Structure

  • 7.1. Demand Supply Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat From New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Regulatory Approvals
  • 9.3. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Noom, Inc.
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products and Services
    • 13.1.4. Financials (As Reported)
    • 13.1.5. Key Market Focus and Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Kaia Health Software, Inc.
  • 13.3. Welldoc, Inc.
  • 13.4. Better Therapeutics, Inc.
  • 13.5. Vida Health, Inc.
  • 13.6. 2Morrow Health, Inc.
  • 13.7. Omada Health, Inc.
  • 13.8. Akili Interactive Labs, Inc.
  • 13.9. Teladoc Health, Inc.
  • 13.10. ConigFit Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 3. Global Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 4. Global Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 5. Global Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 6. Global Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 7. Global Digital Therapeutics Market Share (%), By Region, 2017-2031F
  • Figure 8. North America Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 9. North America Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 10. North America Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 11. North America Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 12. North America Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 13. North America Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 14. North America Digital Therapeutics Market Share (%), By Country, 2017-2031F
  • Figure 15. United States Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. United States Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 17. United States Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 18. United States Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 19. United States Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 20. United States Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 21. Canada Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 22. Canada Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 23. Canada Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 24. Canada Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 25. Canada Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 26. Canada Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 27. Mexico Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 28. Mexico Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 29. Mexico Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 30. Mexico Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 31. Mexico Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 32. Mexico Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 33. Europe Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 34. Europe Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 35. Europe Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 36. Europe Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 37. Europe Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 38. Europe Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 39. Europe Digital Therapeutics Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. Germany Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 42. Germany Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 43. Germany Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 44. Germany Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 45. Germany Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 46. France Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. France Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 48. France Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 49. France Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 50. France Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 51. France Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 52. Italy Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Italy Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 54. Italy Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 55. Italy Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 56. Italy Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 57. Italy Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 58. United Kingdom Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 59. United Kingdom Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 60. United Kingdom Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 61. United Kingdom Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 62. United Kingdom Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 63. United Kingdom Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 64. Russia Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Russia Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 66. Russia Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 67. Russia Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 68. Russia Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 69. Russia Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 70. Netherlands Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 71. Netherlands Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 72. Netherlands Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 73. Netherlands Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 74. Netherlands Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 75. Netherlands Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 76. Spain Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. Spain Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 78. Spain Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 79. Spain Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 80. Spain Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 81. Spain Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 82. Turkey Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. Turkey Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 84. Turkey Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 85. Turkey Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 86. Turkey Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 87. Turkey Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 88. Poland Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Poland Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 90. Poland Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 91. Poland Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 92. Poland Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 93. Poland Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 94. South America Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. South America Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 96. South America Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 97. South America Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 98. South America Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 99. South America Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 100. South America Digital Therapeutics Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. Brazil Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 103. Brazil Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 104. Brazil Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 105. Brazil Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 106. Brazil Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 107. Argentina Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 108. Argentina Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 109. Argentina Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 110. Argentina Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 111. Argentina Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 112. Argentina Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 113. Asia-Pacific Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 114. Asia-Pacific Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 115. Asia-Pacific Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 116. Asia-Pacific Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 117. Asia-Pacific Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 118. Asia-Pacific Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 119. Asia-Pacific Digital Therapeutics Market Share (%), By Country, 2017-2031F
  • Figure 120. India Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 121. India Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 122. India Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 123. India Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 124. India Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 125. India Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 126. China Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. China Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 128. China Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 129. China Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 130. China Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 131. China Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 132. Japan Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 133. Japan Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 134. Japan Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 135. Japan Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 136. Japan Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 137. Japan Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 138. Australia Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 139. Australia Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 140. Australia Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 141. Australia Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 142. Australia Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 143. Australia Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 144. Vietnam Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 145. Vietnam Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 146. Vietnam Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 147. Vietnam Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 148. Vietnam Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 149. Vietnam Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 150. South Korea Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 151. South Korea Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 152. South Korea Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 153. South Korea Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 154. South Korea Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 155. South Korea Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 156. Indonesia Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 157. Indonesia Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 158. Indonesia Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 159. Indonesia Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 160. Indonesia Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 161. Indonesia Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 162. Philippines Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 163. Philippines Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 164. Philippines Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 165. Philippines Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 166. Philippines Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 167. Philippines Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 168. Middle East & Africa Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 169. Middle East & Africa Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 170. Middle East & Africa Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 171. Middle East & Africa Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 172. Middle East & Africa Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 173. Middle East & Africa Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 174. Middle East & Africa Digital Therapeutics Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Saudi Arabia Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 177. Saudi Arabia Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 178. Saudi Arabia Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 179. Saudi Arabia Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 180. Saudi Arabia Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 181. UAE Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. UAE Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 183. UAE Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 184. UAE Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 185. UAE Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 186. UAE Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 187. South Africa Digital Therapeutics Market, By Value, In USD Billion, 2017-2031F
  • Figure 188. South Africa Digital Therapeutics Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 189. South Africa Digital Therapeutics Market Share (%), By Product, 2017-2031F
  • Figure 190. South Africa Digital Therapeutics Market Share (%), By Application, 2017-2031F
  • Figure 191. South Africa Digital Therapeutics Market Share (%), By Revenue Model, 2017-2031F
  • Figure 192. South Africa Digital Therapeutics Market Share (%), By Sales Channel, 2017-2031F
  • Figure 193. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195. By Revenue Model Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196. By Sales Channel Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023